Ochoa AH, Ramírez TG, Madrazo AO, Fernández CM, Romeu CC, Botet GM

Language: Spanish
References: 15
Page: 1-13
PDF size: 349.51 Kb.

ABSTRACT

Introduction: Ciprofloxacin 0.2 % in otic drops constitutes the treatment of choice for outer otitis, but it is not available in the country. As an alternative therapy, ophthalmic solutions are used, which are not always adequate from the physiological and therapeutic point of view.
Objective: To validate a spectrophotometric method for quality control of ciprofloxacin 0.2% otic drop.
Methods: The parameters evaluated corresponded to those established internationally for quantitative techniques. Specificity was evaluated against excipients; linearity in the concentration ranged between 80 and 120 %; accuracy at five concentration levels and precision through repeatability and intermediate precision. In the spectrophotometric method, the absorbances of the reference solution and the sample were determined at 277 nm, using distilled water as solvent. The validated method was applied for the titration of pilot batches of the recently elaborated otic drop formula.
Results: It was demonstrated that the method was quite linear, specific, precise and accurate for the determination of ciprofloxacin content in the otic drop formulation. The titration of the pilot batches, freshly produced, met the established criteria. A simple, reproducible and cost-effective method was validated for quality control of the finished product.
Conclusions: The quantification of ciprofloxacin hydrochloride, through the spectrophotometric method, was specific, linear, precise and accurate, thus demonstrating its application for the quality control of the otic formula.

REFERENCES

1. Mate I, Ordóñez O, Romero A. Otitis externa. Infecciones en pediatría. Guía rápida para la selección del tratamiento antimicrobiano empírico. Guía ABE. Madrid: Grupo de Patología Infecciosa de AEPap (GPI-AEPAP). 2019 [acceso 12/01/2022]. Disponible en: http://www.guia-abe.es

2. Lombana E, Lombana MA, Miranda MC. Otitis externa difusa: ¿una patología trivial? Gaceta Médica Boliviana. 2021;44(2). DOI: 10.47993/gmb.v44i2.268

3. Papadakis MA, McPhee S. Diagnóstico clínico y tratamiento. Enfermedades del oído, nariz y garganta. Enfermedades del canal auditivo. Editores: Papadakis MA, McPhee SJ, Rabow MW. McGraw-Hill Education. 2020 [acceso 12/01/2022]. Disponible en: https://mhmedical.com/searchresults.aspx?q=Enfermedades+del+canal+auditivo&page=1

4. Larach F, Astorquiza C. Otitis externa: diagnóstico y manejo. Revista Médica Clínica Las Condes. 2016;27(6):898-04. DOI: 10.1016/j.rmclc.2016.11.019

5. Colectivo de autores. Cuadro Básico de Medicamentos; Médicas. La Habana: Editorial de Ciencias Médicas; 2019 [acceso 15/02/2021]. Disponible en: https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.cecmed.cu/sites/default/files/adjuntos/vigilancia/farmacov/cuadro_basico_medicamentos_2019.pdf&ved=2ahUKEwj4rISl6uP9AhXDFFkFHaeYC6IQFnoECAcQAQ&usg=AOvVaw18v0WCSaw_zMfwPe1XYI1t

6. United States Pharmacopoeia. US Pharmacopoeia Convention. Rockville: Mack Printing; 2019 [acceso 17/01/2022];42. Disponible en: https://www.uspnf.com/official-text/proposal-statuscommentary/usp-42-nf-37

7. Besada L, Romeu CR, Ramírez G. Validación del método cromatográfico para estudios de estabilidad del ciprofloxacino clorhidrato 0,2 % gota ótica. Rev. Cub Farm. 2022 [acceso 12/01/2022];55(1):e688. Disponible en: http://revfarmacia.sld.cu/index.php/far/issue/view/22

8. Rajia S, Hasan I, Amin R, Islam MA. Efficiency of a cost-effective UV spectrophotometric method for estimation of ciprofloxacin HCl in marketed tablet formulation. Int. J Pharm Sci Res. 2015;6(10):4277-83. DOI: 10.13040/IJPSR.0975-8232.6

9. Gummadi S, Thota D, Varri SV, Vaddi P, Jillella VLNSR. Development and validation of UV spectroscopic methods for simultaneous estimation of ciprofloxacin and tinidazole in tablet formulation. Int Curr Pharm J. 2012 [acceso 17/01/2022];1(10):317-21. Disponible en: http://www.icpjonline.com/documents/Vol1Issue10/03.pdf

10. Alrfaj NA, Razeq SAA, Alsehaly HM. Determination of josamycin and ciprofloxacin in their pharmaceutical dosage forms by spectrophotometry. Asian J Chem. 2011 [acceso 20/01/2022];23(8):3362-66. Disponible en: http://www.asianjournalofchemistry.co

11. Laignier EC, Nunes HR. Spectrophotometric determination of ciprofloxacin hydrochloride in ophthalmic solution. Advances in Analytical Chemistry. 2012;2(6):74-9. DOI: 10.5923/j.aac.20120206.01

12. Laignier EC, Bonfilio R, Araújo M, Nunes HR. A first-derivative spectrophotometric determination of ciprofloxacin hydrochloride in ophthalmic solution. Physical Chemistry. 2012;2(6):116-22. DOI: 10.5923/j.pc.20120206.06

13. Obaydo RH, Sakur AA. Fingerprint spectrophotometric methods for the determination of co-formulated otic solution of ciprofloxacin and fluocinolone acetonide in their challengeable ratio. Journal of Analytical Methods in Chemistry. 2019;2019:1-14. DOI: 10.1155/2019/8919345

14. Obaydo RH, Sakur AA. Spectrophotometric strategies for the analysis of binary combinations with minor component based on isoabsorptive point’s leveling effect: an application on ciprofloxacin and fluocinolone acetonide in their recently delivered co-formulation. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2019;219(5):186-94. DOI: 10.1016/j.saa.2019.04.036

15. Centro para el Control Estatal de la Calidad de los Medicamentos (CECMED). Anexo 1: Buenas Prácticas para Laboratorios de Control de Medicamentos. Validación de métodos analíticos. La Habana: CECMED; 2013 [acceso 17/01/2022]:3-25. Disponible en: https://www.cecmed.cu/sites/default/files/adjuntos/Reglamentacion/